These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2685141)

  • 1. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
    Yaginuma Y; Yamashita K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ras oncogene product p21 expression and prognosis of human ovarian tumors.
    Yaginuma Y; Yamashita K; Kuzumaki N; Fujita M; Shimizu T
    Gynecol Oncol; 1992 Jul; 46(1):45-50. PubMed ID: 1634140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary.
    Kuwashima Y; Shisa H; Uehara T; Kurosumi M; Kobayashi Y; Tanuma J; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of the ras oncogene product p21 in advanced ovarian cancer. Lack of correlation with clinical outcome.
    Rodenburg CJ; Koelma IA; Nap M; Fleuren GJ
    Arch Pathol Lab Med; 1988 Feb; 112(2):151-4. PubMed ID: 3276289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the ras oncoprotein in gastric carcinomas and adjacent mucosa.
    Karayiannis M; Yiagnisis M; Papadimitriou K; Spandidos DA
    Anticancer Res; 1989; 9(6):1505-10. PubMed ID: 2697179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
    Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D; Hirschmann A; Löhrs U; Diebold J
    Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
    Nakajima K
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):573-80. PubMed ID: 3315926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
    Mok SC; Bell DA; Knapp RC; Fishbaugh PM; Welch WR; Muto MG; Berkowitz RS; Tsao SW
    Cancer Res; 1993 Apr; 53(7):1489-92. PubMed ID: 8384077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of LDH-ras p21 protein complex and expression of these genes in human ovarian cancer.
    Chow SN; Lin JK; Li SS; Chien CH
    Gynecol Oncol; 1997 Jan; 64(1):114-20. PubMed ID: 8995558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
    Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
    Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms.
    Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA
    Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical studies of ras oncogene product p21 in 7,12 dimethylbenz (a) anthracene-induced rat ovarian tumors].
    Kataoka A; Hirakawa N; Sugiyama T; Higashijima T; Nishida T; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1209-13. PubMed ID: 1919181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
    Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
    Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of ras oncogene p21 in relation to prognostic factors of human breast cancer].
    Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Ueno Y; Yamashita H; Nomura K; Ichiguchi O
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2271-5. PubMed ID: 1656890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
    Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
    Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the expression of the P21 ras oncogene product and the biological behavior of bladder tumors.
    Miao TJ; Wang Z; Sang N
    Eur Urol; 1991; 20(4):307-10. PubMed ID: 1814747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of the ras oncogene expression in human bladder endoscopy specimens.
    Agnantis NJ; Constantinidou A; Poulios C; Pintzas A; Kakkanas A; Spandidos DA
    Eur J Surg Oncol; 1990 Apr; 16(2):153-60. PubMed ID: 2182341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
    Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.